Antiphospholipid Antibodies in Lupus Nephritis

Lupus nephritis (LN) is a major manifestation of systemic lupus erythematosus (SLE). It remains unclear whether antiphospholipid antibodies (aPL) alter the course of LN. We thus investigated the impact of aPL on short-term and long-term renal outcomes in patients with LN. We assessed levels of aPL c...

Descripción completa

Detalles Bibliográficos
Autores principales: Parodis, Ioannis, Arnaud, Laurent, Gerhardsson, Jakob, Zickert, Agneta, Sundelin, Birgitta, Malmström, Vivianne, Svenungsson, Elisabet, Gunnarsson, Iva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919007/
https://www.ncbi.nlm.nih.gov/pubmed/27336701
http://dx.doi.org/10.1371/journal.pone.0158076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919007/
https://www.ncbi.nlm.nih.gov/pubmed/27336701
http://dx.doi.org/10.1371/journal.pone.0158076

Ejemplares similares